ELV vs MOH vs CRVL Stock Comparison

Elevance Health, Molina Healthcare and Corvel Prices as of Nov 13, 2026 Peers: Industry group
ELV Elevance Health, Inc.
$429.67 +0.4% 1M +30.9% 1Y
Market cap
$96.73B
P/E
18.8x
Revenue (TTM)
$201.83B
Div. yield
–
Managed Care Healthcare
6 wins
MOH Molina Healthcare, Inc.
$209.62 +0.3% 1M +51.4% 1Y
Market cap
$11.89B
P/E
–
Revenue (TTM)
$44.13B
Div. yield
–
Managed Care Healthcare
2 wins
CRVL Corvel Corp
$85.69 +6.6% 1M +16.6% 1Y
Market cap
$4.42B
P/E
36.4x
Revenue (TTM)
$1.01B
Div. yield
–
Managed Care Healthcare
3 wins

Head to Head

11 decided of 12

Elevance Health leads on 6 of the 12 questions below (Elevance Health 6, Corvel 3, Molina Healthcare 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionELVMOHCRVLLeader
Larger companyMarket capitalisation $96.73B $11.89B $4.42B ELV
Cheaper on earningsLower P/E, profitable companies only 18.8x -247.8x 36.4x ELV
Cheaper on forward earningsLower price / next fiscal year consensus EPS 14.3x 41.0x — ELV
Faster revenue growthRevenue growth, trailing twelve months +3.6% -0.9% +8.3% CRVL
More profitableNet margin, trailing twelve months 2.5% -0.1% 12.0% CRVL
Better return on capitalReturn on invested capital 8.3% 2.2% — ELV
Less leveragedLower net debt / EBITDA -0.5x -14.4x — MOH
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +30.9% +51.4% +16.6% MOH
Better 5-year returnAnnualised price return, 5 years -0.3%/yr -7.7%/yr +6.0%/yr CRVL
Less volatileAnnualised volatility, 1 year 35.6% 52.5% 44.1% ELV
Higher overall scoreMean of the five percentile scores vs peers 68/100 36/100 64/100 ELV

Percentile Scorecard

ELVMOHCRVL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisELVMOHCRVL
Valuation 81 #6 of 27 42 #16 of 27 27 #20 of 27
Growth 36 #17 of 26 4 #25 of 26 60 #11 of 26
Profitability 72 #8 of 26 32 #18 of 26 92 #3 of 26
Financial Health 68 #9 of 26 64 #10 of 26 96 #2 of 26
Shareholder Returns 82 #4 of 18 – 47 #10 of 18
Overall 68 36 64
  • ELV ranked among 27 companies in Healthcare Payers and Distributors
  • MOH ranked among 27 companies in Healthcare Payers and Distributors
  • CRVL ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodELVMOHCRVLSPY
1 month +0.4%+0.3%+6.6% -2.0%
3 months +7.3%-1.3%+30.4% -2.8%
6 months +9.4%+13.3%+50.0% +2.0%
Year to date +22.6%+20.8%+26.6% +10.6%
1 year +30.9%+51.4%+16.6% +12.2%
3 years -6.9%-42.2%+20.0% +68.1%
3 years, per year -2.4%-16.7%+6.3% +18.9%
5 years -1.7%-33.1%+34.0% +61.4%
5 years, per year -0.3%-7.7%+6.0% +10.1%
10 years +221.4%+341.0%+703.3% +248.5%
10 years, per year +12.4%+16.0%+23.2% +13.3%

Risk

MeasureELVMOHCRVLSPY
Volatility, 1Y 35.6%52.5%44.1% 13.6%
Downside volatility, 1Y 38.1%57.9%53.6% 13.9%
Beta vs S&P 500, 1Y 0.29-0.010.06 1.00
Return / volatility, 1Y 0.870.980.38 0.90
Max drawdown, 5Y -51.2%-70.8%-64.2% -25.4%
From 52-week high -3.5%-13.7%-1.9% -3.2%
52-week high $445.45$242.88$87.38 $779.14
52-week low $280.74$122.65$46.00 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleELVMOHCRVL
P/E now vs peer median 18.1xmedian 25.2x -223.6xmedian 25.2x 35.6xmedian 25.2x
P/S now vs peer median 0.5xmedian 0.4x 0.2xmedian 0.4x 4.3xmedian 0.4x
EV/EBITDA now vs peer median 9.6xmedian 14.5x 18.3xmedian 14.5x 20.7xmedian 14.5x
P/FCF now vs peer median 14.3xmedian 16.5x 45.8xmedian 16.5x 33.8xmedian 16.5x
P/B now vs peer median 2.1xmedian 2.7x 2.6xmedian 2.7x 10.0xmedian 2.7x
PEG now vs peer median -7.75median 1.72 8.22median 1.72 1.91median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsELVMOHCRVL
Revenue $201.83B $44.13B $1.01B
Gross profit $53.35B $5.56B $258.02M
Operating income $7.70B $172.00M $161.13M
Net income $5.13B -$48.00M $121.52M
Free cash flow $6.51B $238.00M $127.86M
EPS (diluted) $23.62 $-0.93 $2.40
Cash & equivalents $10.35B $4.48B $269.99M
Total debt $30.76B $3.77B –
Shares (diluted) 217.60M 51.50M 50.69M
Enterprise value -$45.86B -$23.11B $3.43B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricELVMOHCRVL
P/E 18.1x -223.6x 35.6x
P/FCF 14.3x 45.8x 33.8x
P/Operating cash flow 12.2x 32.9x 26.2x
P/S 0.5x 0.2x 4.3x
P/B 2.1x 2.6x 10.0x
P/Tangible book 2.7x 2.6x 10.0x
EV/EBITDA 9.6x 18.3x 20.7x
EV/EBIT 11.4x 35.4x 25.1x
EV/Revenue 0.4x 0.1x 4.0x
EV/FCF 13.5x 25.6x 31.7x
EV/Operating cash flow 11.6x 18.4x 24.5x
PEG (3Y EPS CAGR) -7.75 8.22 1.91

Growth

14 metrics
MetricELVMOHCRVL
Revenue growth (1Y) 3.6% -0.9% 8.3%
Revenue CAGR (3Y) 6.2% 9.9% 10.4%
Gross profit growth (1Y) 4.3% -10.2% 14.2%
Gross profit CAGR (3Y) 5.5% 3.3% 15.3%
Operating income growth (1Y) -9.2% -87.0% 19.1%
Operating income CAGR (3Y) -4.2% -49.8% 19.3%
Net income growth (1Y) -7.4% -105.4% 15.4%
Net income CAGR (3Y) -5.2% -27.1% 17.6%
EPS growth (1Y) -4.5% -105.5% 17.7%
EPS CAGR (3Y) -2.3% -27.2% 18.6%
Operating cash flow growth (1Y) 54.6% 171.8% 14.2%
Operating cash flow CAGR (3Y) -7.2% -46.3% 19.3%
Free cash flow growth (1Y) 72.9% 141.5% 26.4%
Free cash flow CAGR (3Y) -7.6% -51.1% 21.1%

Profitability

14 metrics
MetricELVMOHCRVL
Gross margin 26.4% 12.6% 25.5%
EBITDA margin 4.6% 0.8% 19.3%
Operating margin 3.8% 0.4% 15.9%
Pretax margin 3.1% -0.1% 15.9%
Net margin 2.5% -0.1% 12.0%
FCF margin 3.2% 0.5% 12.6%
Operating cash flow margin 3.8% 0.8% 16.3%
Return on equity 11.4% -1.2% 29.0%
Return on assets 4.0% -0.3% 17.3%
Return on invested capital 8.3% 2.2% –
Return on capital employed 9.6% 2.0% 36.3%
Asset turnover 1.6x 2.8x 1.4x
Cash conversion (OCF / net income) 1.5x -6.9x 1.4x
Stock comp / revenue 0.1% 0.2% 0.5%

Financial Health

11 metrics
MetricELVMOHCRVL
Debt / assets 24.1% 24.1% –
Debt / equity 0.7x 0.9x –
Net debt / EBITDA -0.5x -14.4x –
Debt / FCF 4.7x 15.8x –
Liabilities / assets 65.0% 73.5% 39.7%
Equity / assets 35.0% 26.5% 60.3%
Interest coverage 5.3x 0.8x –
Current ratio 1.5x 1.7x 2.0x
Quick ratio 1.2x 1.6x 1.6x
Cash ratio 0.8x 1.2x 1.0x
Altman Z-score 3.06 4.15 13.88

Shareholder Returns

7 metrics
MetricELVMOHCRVL
Dividend yield 1.6% – –
Net buyback yield 2.2% – 0.7%
Shareholder yield 3.8% – 0.7%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusELVMOHCRVL
Forward P/E 14.3xFY2026 41.0xFY2026 –
EPS, next fiscal year $30.12FY2026 $5.11FY2026 –
EPS growth, next FY -0.6%FY2026 -53.7%FY2026 –
EPS growth, the year after +4.2% +93.0% –
Revenue, next fiscal year $211.92BFY2026 $41.59BFY2026 –
Revenue growth, next FY +7.3%FY2026 -8.5%FY2026 –
Revenue growth, the year after +0.0% +20.4% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersELVMOHCRVL
Held by institutions 91.8% 100.0% 54.5%
Institutions holding 1,615 600 288
Change in shares held, QoQ +1.7% +1.2% +2.3%
Institutions buying 862 364 172
Institutions selling 542 170 72
Buyers to sellers 1.59 2.14 2.39

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ELVMOHCRVL
ELV 1.00 0.46 0.23
MOH 0.46 1.00 0.14
CRVL 0.23 0.14 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ELV, MOH and CRVL?

Elevance Health (ELV) is the largest by market capitalisation: Elevance Health (ELV) $96.73B, Molina Healthcare (MOH) $11.89B, Corvel (CRVL) $4.42B.

Which stock is cheaper, ELV, MOH and CRVL?

Elevance Health (ELV) trades on the lowest price-to-earnings ratio (Elevance Health (ELV) 18.8x, Molina Healthcare (MOH) -247.8x, Corvel (CRVL) 36.4x). On next year's consensus earnings, Elevance Health (ELV) is cheapest (Elevance Health (ELV) 14.3x, Molina Healthcare (MOH) 41.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Corvel (CRVL) grew revenue fastest over the trailing twelve months: Elevance Health (ELV) +3.6%, Molina Healthcare (MOH) -0.9%, Corvel (CRVL) +8.3%.

Which company is more profitable?

Corvel (CRVL) has the highest net margin (Elevance Health (ELV) 2.5%, Molina Healthcare (MOH) -0.1%, Corvel (CRVL) 12.0%). On return on invested capital, Elevance Health (ELV) leads (Elevance Health (ELV) 8.3%, Molina Healthcare (MOH) 2.2%).

Which stock has performed better?

Over the past year Molina Healthcare (MOH) returned the most: Elevance Health (ELV) +30.9%, Molina Healthcare (MOH) +51.4%, Corvel (CRVL) +16.6%. Over five years, Corvel (CRVL) compounded fastest (Elevance Health (ELV) -0.3%/yr, Molina Healthcare (MOH) -7.7%/yr, Corvel (CRVL) +6.0%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Elevance Health (ELV) has been the steadiest (Elevance Health (ELV) 35.6%, Molina Healthcare (MOH) 52.5%, Corvel (CRVL) 44.1%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ELV, MOH and CRVL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Elevance Health (ELV) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.